Journal
Cell Reports Medicine
Publication Date
12-19-2023
Volume
4
Issue
12
First Page
101305
Document Type
Open Access Publication
DOI
10.1016/j.xcrm.2023.101305
Rights and Permissions
Adams LJ, VanBlargan LA, Liu Z, Gilchuk P, Zhao H, Chen RE, Raju S, Chong Z, Whitener BM, Shrihari S, Jethva PN, Gross ML, Crowe JE Jr, Whelan SPJ, Diamond MS, Fremont DH. A broadly reactive antibody targeting the N-terminal domain of SARS-CoV-2 spike confers Fc-mediated protection. Cell Rep Med. 2023 Dec 19;4(12):101305. doi: 10.1016/j.xcrm.2023.101305. Copyright 2023 The Author(s). This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Recommended Citation
Adams, Lucas J; VanBlargan, Laura A; Liu, Zhuoming; Gilchuk, Pavlo; Zhao, Haiyan; Chen, Rita E; Raju, Saravanan; Chong, Zhenlu; Whitener, Bradley M; Shrihari, Swathi; Jethva, Prashant N; Gross, Michael L; Crowe, James E Jr.; Whelan, Sean P J; Diamond, Michael S; and Fremont, Daved H, "A broadly reactive antibody targeting the N-terminal domain of SARS-CoV-2 spike confers Fc-mediated protection." Cell Reports Medicine. 4, 12. 101305 (2023).
https://digitalcommons.wustl.edu/oa_4/3593
Department
ICTS (Institute of Clinical and Translational Sciences)
